arrow
G

Guillaume Bouguen

Ecole Normale Superieure de Lyon
H指数:46
被引数:8,988

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study

甲氨蝶呤治疗炎症性肠病:MICI-METHO多中心回顾性队列研究

2026-07-220
PRE
Real world experience with granulocyte and monocyte adsorptive apheresis (ADACOLUMN®) in patients with refractory inflammatory bowel disease: a retrospective observational multicenter cohort study

粒细胞和单核细胞吸附性单采(ADACOLUMN®)在难治性炎症性肠病患者中的真实世界经验:一项回顾性多中心队列研究

2026-07-010
PRE
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID

在溃疡性结肠炎中,继维多利珠单抗后的二线高级治疗的疗效与安全性:一项来自GETAID的多中心队列研究

2026-03-250
OAAI
A healthy diet is associated with sustained remission and low relapse rates in Inflammatory bowel disease: a prospective e-cohort study

健康饮食与炎症性肠病持续缓解和低复发率相关:一项前瞻性电子队列研究

2026-01-010
PRE
One-Year Effectiveness and Safety of Upadacitinib in 261 Patients With Crohn's Disease: A Multicenter Real-World Cohort Study

乌帕替尼在261例克罗恩病患者中的一年有效性与安全性:一项多中心真实世界队列研究

2026-01-010
PRE
Comparison of effectiveness between Vedolizumab and Filgotinib in patients with ulcerative colitis previously exposed to at least one anti-TNF agent: Results from the real-world evidence multicenter VEDOFIL study

比较Vedolizumab和Filgotinib在既往至少接受过一种抗-TNF制剂治疗的溃疡性结肠炎患者中的疗效:VEDOFIL真实世界证据多中心研究的结果

2026-01-010
PRE
Comparative Effectiveness of Advanced Therapies between Ulcerative Proctitis and More Extensive Forms of Ulcerative Colitis: Results from a Multicenter Real-World Study

比较溃疡性直肠炎与更广泛型溃疡性结肠炎对先进疗法疗效的差异:多中心真实世界研究的结果

2026-01-010
PRE
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study

比较标准与强化肺炎球菌疫苗接种方案在应用生物制剂治疗的炎症性肠病患者中的效果:一项前瞻性、多中心、随机、开放标签研究

2025-08-250
PRE
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission

IBD缓解期患者从静脉给药途径转换为皮下给药途径1年后英夫利昔单抗的持续疗效与安全性

2025-05-190
PRE
Endoscopic submucosal dissection for visible dysplasia in inflammatory bowel disease: a nationwide multicenter cohort from the GETAID and the SFED

炎症性肠病中可见异型增生的内镜黏膜下剥离术:来自GETAID和SFED的全国多中心队列研究

2025-04-250
PRE
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study

乌帕替尼诱导治疗223例克罗恩病患者的有效性与安全性:一项GETAID多中心队列研究

2025-03-042
OAAI